Hemosol

HML-T

0.00
0.00 (0.00%)
This company is not ACTIVE.

Analysis and Opinions about HML-T

Signal
Opinion
Expert
DON'T BUY
DON'T BUY
September 4, 2001
Phase 3 stage required restructuring so competitors now have a year's head start.
Show full opinionHide full opinion
Hemosol (HML-T)
September 4, 2001
Phase 3 stage required restructuring so competitors now have a year's head start.
DON'T BUY
DON'T BUY
August 31, 2001
Biotechs can have a drop if the core product doesn't work out. Speculative.
Show full opinionHide full opinion
Hemosol (HML-T)
August 31, 2001
Biotechs can have a drop if the core product doesn't work out. Speculative.
WEAK BUY
WEAK BUY
August 24, 2001
Will be 6/9 months before getting approval. Good price.
Show full opinionHide full opinion
Hemosol (HML-T)
August 24, 2001
Will be 6/9 months before getting approval. Good price.
DON'T BUY
DON'T BUY
August 16, 2001
Not sure there will be the demand for a blood substitute. Can/will clients change their systems to accommodate?
Show full opinionHide full opinion
Hemosol (HML-T)
August 16, 2001
Not sure there will be the demand for a blood substitute. Can/will clients change their systems to accommodate?
BUY
BUY
August 15, 2001
FDA has delayed. Expect them to back on track in 6/9 months. Good price.
Show full opinionHide full opinion
Hemosol (HML-T)
August 15, 2001
FDA has delayed. Expect them to back on track in 6/9 months. Good price.
HOLD
HOLD
August 14, 2001
FDA knocked them back. Look for signs that they are getting back to basics and they revise their applications.
Show full opinionHide full opinion
Hemosol (HML-T)
August 14, 2001
FDA knocked them back. Look for signs that they are getting back to basics and they revise their applications.
BUY
BUY
August 3, 2001
Still waiting to get approval. Should be good.
Show full opinionHide full opinion
Hemosol (HML-T)
August 3, 2001
Still waiting to get approval. Should be good.
DON'T BUY
DON'T BUY
August 1, 2001
Should get product approved, but not sure that demand will be strong. Also has competition.
Show full opinionHide full opinion
Hemosol (HML-T)
August 1, 2001
Should get product approved, but not sure that demand will be strong. Also has competition.
HOLD
HOLD
June 22, 2001
Having problems getting distribution/approvals.
Show full opinionHide full opinion
Hemosol (HML-T)
June 22, 2001
Having problems getting distribution/approvals.
DON'T BUY
DON'T BUY
June 7, 2001
Will be a market for the product, but has competition and not sure how big the market will be.
Show full opinionHide full opinion
Hemosol (HML-T)
June 7, 2001
Will be a market for the product, but has competition and not sure how big the market will be.
DON'T BUY
DON'T BUY
June 6, 2001
Preliminary approval in Canada & Europe and in final phase in US. Expensive treatment. Covered by government/health ins. ?
Show full opinionHide full opinion
Hemosol (HML-T)
June 6, 2001
Preliminary approval in Canada & Europe and in final phase in US. Expensive treatment. Covered by government/health ins. ?
DON'T BUY
DON'T BUY
May 25, 2001
Better to own it through MDS
Show full opinionHide full opinion
Hemosol (HML-T)
May 25, 2001
Better to own it through MDS
DON'T BUY
DON'T BUY
May 24, 2001
Good products in final phase, but a one trick pony.
Show full opinionHide full opinion
Hemosol (HML-T)
May 24, 2001
Good products in final phase, but a one trick pony.
BUY
BUY
April 18, 2001
Still waiting approval. Once that happens, stock should move up.
Show full opinionHide full opinion
Hemosol (HML-T)
April 18, 2001
Still waiting approval. Once that happens, stock should move up.
Ed Ho

Unlock Ratings

Price
$14.000
Owned
Unknown
STRONG BUY
STRONG BUY
March 27, 2001
Got US financing. Getting US attention now (analyst has $18US) Look for new partner announcements in Europe.
Show full opinionHide full opinion
Hemosol (HML-T)
March 27, 2001
Got US financing. Getting US attention now (analyst has $18US) Look for new partner announcements in Europe.
Showing 46 to 60 of 78 entries